NCT00165867已完成2 期
An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 14
- 主要终点
- The objective response rate as defined by RECIST criteria.
研究概览
简要总结
The overall purpose of this study is to determine the efficacy, safety and tolerability of indisulam in combination with irinotecan as a treatment for patients with metastatic colorectalcancer previously treated with 5-fluorouracil/leucovorin and oxaliplatin (FOLFOX).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The objective response rate as defined by RECIST criteria.
次要结局
- Duration of response
- time to progression
- overall survival
- safety and tolerability of the combination
研究者
研究点 (14)
Loading locations...
相似试验
终止
2 期
An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With CapecitabineMetastatic Breast CancerNCT00165880Eisai Limited62
已完成
2 期
Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)Diabetes Mellitus Type 2NCT01889667Oramed, Ltd.30
进行中（未招募）
2 期
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of TherapiesPrimary Immune Thrombocytopenia (ITP)NCT05885555Novartis Pharmaceuticals41
已完成
2 期
Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS SyndromePOEMS SyndromeNCT01816620Peking Union Medical College Hospital41
已完成
2 期
A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis VulgarisPsoriasis VulgarisNCT02106195Kadmon Corporation, LLC8